Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Developing countries get free access to Spanish COVID testing tech

Developing countries get free access to Spanish COVID testing tech

Spain's public medical research body and the World Health Organization struck a deal that could make COVID testing cheaper and more accessible for poorer nations.

COVID-19 testing in developing countries could be about to get a lot cheaper, thanks to Spanish government researchers who have provided their antibody tests royalty-free to a World Health Organization (WHO) and UN-backed technology pool.

The non-exclusive agreement reached with the Spanish National Research Council (CSIC), a public research institute offering the technology as a global public good, is the first time a COVID-19 health tool has been licensed by the Medicines Patent Pool (MPP).

The agreement, which was announced on Tuesday, means that other manufacturers will be able to make the tests without buying a licence, lowering costs and making them easier to produce.

"This is the kind of open and transparent licence we need to move the needle on access during and after the pandemic," said WHO director general Tedros Adhanom Ghebretyesus.

"I urge developers of COVID-19 vaccines, treatments and diagnostics to follow this example and turn the tide on the pandemic and on the devastating global inequity this pandemic has spotlighted".

What's in the COVID test agreement?


The CSIC's serological tests can detect whether a person has antibodies against COVID-19, as well as whether they are the result of being vaccinated or being infected with the virus.

The tests are simple to use and suitable for areas with limited access to laboratory facilities, the MPP said in a statement.

WHO director general Tedros Adhanom Ghebretyesus urged other developers to follow the CSIC's lead


"The novelty of the agreement is that CSIC will not charge royalties for the exploitation of its technology as long as it is manufactured for or in countries included in the list of low and medium income countries," said CSIC's Javier Maira.

Companies that produce the tests will also have to adjust the price to make them affordable in each country where they are marketed, the CSIC added.

A pandemic of inequality


Unequal access to treatments and diagnostic tools for COVID-19 has been one of the defining features of the pandemic.

Despite international efforts like the COVAX programme to provide COVID-19 vaccines to poorer nations, less than 1 per cent of the world's supply has made it to developing countries.

"We have witnessed hoarding of not just vaccines and treatments but also of COVID-19 diagnostics, which has left many low- and middle-income countries without much-needed tests to help in controlling COVID-19," Stijn Deborggraeve, adviser to a vaccine access campaign run by medical charity Doctors Without Borders (MSF), said.

Last week, the MPP signed another agreement with pharmaceutical giant Pfizer for its antiviral drug Paxlovid.

The company's COVID-19 vaccine is not part of the deal, however, leading campaigners to call for further action to reduce unequal access to treatments for the virus.

"It is clear that relying on the voluntary actions of pharmaceutical companies alone will not secure urgently needed access to tests, medicines and vaccines for everyone, everywhere," said aid charity Oxfam.

"Only concerted action by governments to force them to share technology, know-how, and intellectual property will achieve this".

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
Amazon Reaches Major Automation Milestone with Over One Million Robots
Extreme Heat Wave Sweeps Across Europe, Hitting Record Temperatures
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
Robots Compete in Football Tournament in China Amid Injuries
China Unveils Miniature Insect-Like Surveillance Drone
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Germany Votes to Suspend Family Reunification for Asylum Seekers
Budapest Pride Parade Draws 200,000 Participants Amid Government Ban
Southern Europe Experiences Extreme Heat
Xiaomi's YU7 SUV Launch Garners Record Pre-Orders Amid Market Challenges
×